143 related articles for article (PubMed ID: 32979691)
1. Optimizing screening for depression, anxiety disorders, and post-traumatic stress disorder in inpatient addiction treatment: A preliminary investigation.
Levitt EE; Syan SK; Sousa S; Costello MJ; Rush B; Samokhvalov AV; McCabe RE; Kelly J; MacKillop J
Addict Behav; 2021 Jan; 112():106649. PubMed ID: 32979691
[TBL] [Abstract][Full Text] [Related]
2. A Web-based screening instrument for depression and anxiety disorders in primary care.
Farvolden P; McBride C; Bagby RM; Ravitz P
J Med Internet Res; 2003; 5(3):e23. PubMed ID: 14517114
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of the Depression, Anxiety and Stress Scale (DASS-21) for Screening on Comorbid Internalizing Disorders among Youth in Substance Use Disorder Treatment.
Moska C; Goudriaan AE; Blanken P; Hendriks V
Eur Addict Res; 2023; 29(6):385-393. PubMed ID: 37848011
[TBL] [Abstract][Full Text] [Related]
4. Validation of brief screening measures for depression and anxiety in young people with substance use disorders.
Bentley KH; Sakurai H; Lowman KL; Rines-Toth L; McKowen J; Pedrelli P; Evins AE; Yule AM
J Affect Disord; 2021 Mar; 282():1021-1029. PubMed ID: 33601674
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care.
Gaynes BN; DeVeaugh-Geiss J; Weir S; Gu H; MacPherson C; Schulberg HC; Culpepper L; Rubinow DR
Ann Fam Med; 2010; 8(2):160-9. PubMed ID: 20212303
[TBL] [Abstract][Full Text] [Related]
6. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe.
Chibanda D; Verhey R; Gibson LJ; Munetsi E; Machando D; Rusakaniko S; Munjoma R; Araya R; Weiss HA; Abas M
J Affect Disord; 2016 Jul; 198():50-5. PubMed ID: 27011359
[TBL] [Abstract][Full Text] [Related]
7. Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome.
Snijkers JTW; van den Oever W; Weerts ZZRM; Vork L; Mujagic Z; Leue C; Hesselink MAM; Kruimel JW; Muris JWM; Bogie RMM; Masclee AAM; Jonkers DMAE; Keszthelyi D
Neurogastroenterol Motil; 2021 Dec; 33(12):e14161. PubMed ID: 33938601
[TBL] [Abstract][Full Text] [Related]
8. Examining the psychometric properties of brief screening measures of depression and anxiety in chronic pain: The Patient Health Questionnaire 2-item and Generalized Anxiety Disorder 2-item.
Bisby MA; Karin E; Scott AJ; Dudeney J; Fisher A; Gandy M; Hathway T; Heriseanu AI; Staples L; Titov N; Dear BF
Pain Pract; 2022 Apr; 22(4):478-486. PubMed ID: 35258171
[TBL] [Abstract][Full Text] [Related]
9. German translation and validation of the brief Epilepsy Anxiety Survey Instrument (brEASI).
Michaelis R; Schlömer S; Popkirov S; Krämer G; Lindemann A; Cosentino M; Reuber M; Heinen G; Wellmer J; Grönheit W; Wehner T; Schlegel U; Scott AJ; Gandy M
Epilepsy Behav; 2022 Sep; 134():108857. PubMed ID: 35907288
[TBL] [Abstract][Full Text] [Related]
10. Examining brief and ultra-brief anxiety and depression screening methods in a real-world epilepsy clinic sample.
Munger Clary HM; Wan M; Conner K; Brenes GA; Kimball J; Kim E; Duncan P; Snively BM
Epilepsy Behav; 2021 May; 118():107943. PubMed ID: 33839449
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of brief PTSD screening instruments in military veterans.
Tiet QQ; Schutte KK; Leyva YE
J Subst Abuse Treat; 2013 Jul; 45(1):134-42. PubMed ID: 23506779
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample.
Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A
Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447
[TBL] [Abstract][Full Text] [Related]
13. Burden of common mental disorders in a community health centre sample.
Ahmad F; Shakya Y; Ginsburg L; Lou W; Ng PT; Rashid M; Ferrari M; Ledwos C; McKenzie K
Can Fam Physician; 2016 Dec; 62(12):e758-e766. PubMed ID: 27965352
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].
Yao SN; Cottraux J; Note I; De Mey-Guillard C; Mollard E; Ventureyra V
Encephale; 2003; 29(3 Pt 1):232-8. PubMed ID: 12876547
[TBL] [Abstract][Full Text] [Related]
15. The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients.
Esser P; Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
Psychooncology; 2018 Jun; 27(6):1509-1516. PubMed ID: 29473255
[TBL] [Abstract][Full Text] [Related]
16. Psychometric Validation of PHQ-9 and GAD-7 in Filipino Migrant Domestic Workers in Macao (SAR), China.
Garabiles MR; Lao CK; Yip P; Chan EWW; Mordeno I; Hall BJ
J Pers Assess; 2020; 102(6):833-844. PubMed ID: 31361153
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the Hopkins symptom checklist-10 and diagnoses of anxiety and depression among inpatients with substance use disorders.
Andersson HW; Nordfjærn T; Mosti MP
Nord J Psychiatry; 2024 May; 78(4):319-327. PubMed ID: 38421343
[TBL] [Abstract][Full Text] [Related]
18. Psychological Symptoms Among Evacuees From the 2016 Fort McMurray Wildfires: A Population-Based Survey One Year Later.
Belleville G; Ouellet MC; Lebel J; Ghosh S; Morin CM; Bouchard S; Guay S; Bergeron N; Campbell T; MacMaster FP
Front Public Health; 2021; 9():655357. PubMed ID: 34017813
[No Abstract] [Full Text] [Related]
19. Validation of the Generalized Anxiety Disorder-7 (GAD-7) in Russian people with epilepsy.
Zinchuk M; Kustov G; Pashnin E; Gersamia A; Rider F; Yakovlev A; Voinova N; Popova S; Avedisova A; Guekht A
Epilepsy Behav; 2021 Oct; 123():108269. PubMed ID: 34500434
[TBL] [Abstract][Full Text] [Related]
20. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.
Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A
BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
